The present work supports the most recent studies [14, 25, 40] suggesting that FGL1 may exert a protective function during the progression of steatosis, but its exact contribution and the mechanism regulating Fgl1 expression during metabolic alterations are still unknown. The gene discussed is FGL1; the disease is steatosis.